BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30871880)

  • 1. Dysregulated DNA methylation of GLA gene was associated with dysfunction of autophagy.
    Yanagisawa H; Hossain MA; Miyajima T; Nagao K; Miyashita T; Eto Y
    Mol Genet Metab; 2019 Apr; 126(4):460-465. PubMed ID: 30871880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation impact on Fabry disease.
    Di Risi T; Vinciguerra R; Cuomo M; Della Monica R; Riccio E; Cocozza S; Imbriaco M; Duro G; Pisani A; Chiariotti L
    Clin Epigenetics; 2021 Feb; 13(1):24. PubMed ID: 33531072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The severe clinical phenotype for a heterozygous Fabry female patient correlates to the methylation of non-mutated allele associated with chromosome 10q26 deletion syndrome.
    Hossain MA; Yanagisawa H; Miyajima T; Wu C; Takamura A; Akiyama K; Itagaki R; Eto K; Iwamoto T; Yokoi T; Kurosawa K; Numabe H; Eto Y
    Mol Genet Metab; 2017 Mar; 120(3):173-179. PubMed ID: 28087245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay.
    Rossanti R; Nozu K; Fukunaga A; Nagano C; Horinouchi T; Yamamura T; Sakakibara N; Minamikawa S; Ishiko S; Aoto Y; Okada E; Ninchoji T; Kato N; Maruyama S; Kono K; Nishi S; Iijima K; Fujii H
    Clin Exp Nephrol; 2021 Nov; 25(11):1224-1230. PubMed ID: 34128148
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li P; Xi Y; Zhang Y; Samad A; Lan W; Wu Y; Zhao J; Chen G; Wu C; Xiong Q
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
    Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
    Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls of X-chromosome inactivation testing in females with Fabry disease.
    Řeboun M; Sikora J; Magner M; Wiederlechnerová H; Černá A; Poupětová H; Štorkánova G; Mušálková D; Dostálová G; Goláň L; Linhart A; Dvořáková L
    Am J Med Genet A; 2022 Jul; 188(7):1979-1989. PubMed ID: 35338595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Characterization and Pharmacological Evaluation of a Novel GLA Missense Mutation Found in a Severely Affected Fabry Disease Family.
    Varela P; Mastroianni Kirsztajn G; Ferrer H; Aranda C; Wallbach K; Ferreira da Mata G; Moura LA; Moreira SR; Mendes C; Curiati MA; Martins AM; Bosco Pesquero J
    Nephron; 2020; 144(3):147-155. PubMed ID: 31665721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evaluation of a novel GLA causative mutation in Fabry disease.
    Li P; Zhang L; Xiong Q; Wang Z; Cui X; Zhou YA; Wang Y; Xiao H; Wu C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e864. PubMed ID: 31321922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.
    Ivanova MM; Changsila E; Iaonou C; Goker-Alpan O
    PLoS One; 2019; 14(1):e0210617. PubMed ID: 30633777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of Fabry disease as a result of paternal germline mosaicism for alpha-galactosidase a gene mutation.
    Dobrovolný R; Dvoráková L; Ledvinová J; Magage S; Bultas J; Lubanda JC; Poupetová H; Elleder M; Karetová D; Hrebícek M
    Am J Med Genet A; 2005 Apr; 134A(1):84-7. PubMed ID: 15712198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female Fabry disease patients and X-chromosome inactivation.
    Juchniewicz P; Kloska A; Tylki-Szymańska A; Jakóbkiewicz-Banecka J; Węgrzyn G; Moskot M; Gabig-Cimińska M; Piotrowska E
    Gene; 2018 Jan; 641():259-264. PubMed ID: 29079200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
    Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
    BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
    Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
    Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is standard GLA gene mutation analysis definitive for the diagnosis of Fabry disease?
    Mignani R; Morrone A
    Kidney Int; 2009 May; 75(10):1115-6; author reply 1115. PubMed ID: 19404287
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
    Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
    Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles.
    Oder D; Vergho D; Ertl G; Wanner C; Nordbeck P
    BMC Med Genet; 2016 Jul; 17(1):46. PubMed ID: 27431810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.
    Dobrovolny R; Dvorakova L; Ledvinova J; Magage S; Bultas J; Lubanda JC; Elleder M; Karetova D; Pavlikova M; Hrebicek M
    J Mol Med (Berl); 2005 Aug; 83(8):647-54. PubMed ID: 15806320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant mRNA expression in an endomyocardial biopsy sample obtained from a patient with a cardiac variant of Fabry disease caused by a novel acceptor splice site mutation in the invariant AG of intron 5 of the α-galactosidase A gene.
    Watanabe T; Hanawa H; Suzuki T; Jiao S; Yoshida K; Ogura M; Ohno Y; Hayashi Y; Ito M; Kashimura T; Obata H; Sato A; Ozawa T; Kodama M; Sakuraba H; Minamino T
    Intern Med; 2013; 52(7):777-80. PubMed ID: 23545674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.
    Redonnet-Vernhet I; Ploos van Amstel JK; Jansen RP; Wevers RA; Salvayre R; Levade T
    J Med Genet; 1996 Aug; 33(8):682-8. PubMed ID: 8863162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.